<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371938">
  <stage>Registered</stage>
  <submitdate>29/11/2016</submitdate>
  <approvaldate>2/12/2016</approvaldate>
  <actrnumber>ACTRN12616001666415</actrnumber>
  <trial_identification>
    <studytitle>Pharmacokinetics of azithromycin 1 gram single dose in anorectal tissue and serum </studytitle>
    <scientifictitle>Pharmacokinetics of azithromycin 1 gram single dose in anorectal tissue and serum in healthy men</scientifictitle>
    <utrn>NIL</utrn>
    <trialacronym>NIL</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>rectal chlamydia</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Sexually transmitted infections</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Azithromycin 1g single dose (oral tablet), with food by direct observation.</interventions>
    <comparator>NIL</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Anorectal tissue sample concentrations (mcg/g) of azithromycin post-dose</outcome>
      <timepoint>Baseline (pre-dose), 2 hours, 24 hours and days 2,3,4,7,10 and 14 post dose
</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Blood concentration (mcg/mL) post azithromycin dose</outcome>
      <timepoint>2 hours post-dose </timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>NIL</outcome>
      <timepoint>NIL</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- Men who are HIV/STI free and chlamydia negative
- Men aged 18 years and over
- Adequate English and comprehension skills to give informed consent
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>- Self-report of antibiotic use in the last 2 weeks
- Current commercial sex work
- Men who do not have a mobile phone
- HIV positive status
- Concurrent medication likely to significantly interact with azithromycin (e.g. cyclosporine, digoxin)
- Known macrolide allergy or contraindications
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>NIL</concealment>
    <sequence>NIL</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>NIL</designfeatures>
    <endpoint />
    <statisticalmethods>Descriptive and pharmacokinetic analysis of  azithromycin  concentrations in tissue and blood </statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate>31/03/2016</actualenddate>
    <samplesize>10</samplesize>
    <actualsamplesize>10</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>30/04/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <postcode>3053 - Carlton</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Melbourne</primarysponsorname>
    <primarysponsoraddress>Level 3, 207 Bouverie st
Carlton South, Victoria, 3053</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Melbourne</fundingname>
      <fundingaddress>Level 3, 207 Bouverie st
Carlton South, Victoria, 3053
</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>NIL</sponsorname>
      <sponsoraddress>NIL</sponsoraddress>
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>There are increasing concerns regarding the treatment efficacy of azithromycin 1g single dose for the treatment of rectal chlamydia infections with treatment failure rates up to 21% being reported.

There is no pharmacokinetic data available to determine if low rectal tissue concentrations contribute to treatment failure. 

The purpose of this study is to provide the world first evidence of the pharmacokinetics of azithromycin 1g in rectal tissue</summary>
    <trialwebsite>NIL</trialwebsite>
    <publication>NIL</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Alfred Health Human Ethics Committee</ethicname>
      <ethicaddress>Alfred Hospital
55 Commercial Rd, Melbourne VIC 3004</ethicaddress>
      <ethicapprovaldate>2/07/2015</ethicapprovaldate>
      <hrec>267/15</hrec>
      <ethicsubmitdate>22/05/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Jane Hocking</name>
      <address>University of Melbourne
Level 3, 207 Bouverie st
Carlton South 3053
Victoria, Australia</address>
      <phone>+61 3 8344 0762</phone>
      <fax>+61 3 9349 5815</fax>
      <email>jhocking@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jane Hocking</name>
      <address>University of Melbourne
Level 3, 207 Bouverie st
Carlton South 3053
Victoria, Australia</address>
      <phone>+61 3 8344 0762</phone>
      <fax>+61 3 9349 5815</fax>
      <email>jhocking@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Jane Hocking</name>
      <address>University of Melbourne
Level 3, 207 Bouverie st
Carlton South 3053
Victoria, Australia</address>
      <phone>+61 3 8344 0762</phone>
      <fax>+61 3 9349 5815</fax>
      <email>jhocking@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Fabian Kong</name>
      <address>University of Melbourne
Level 3, 207 Bouverie st
Carlton South 3053
Victoria, Australia</address>
      <phone>+61 3 9035 3039</phone>
      <fax>+61 3 9349 5815</fax>
      <email>kongf@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>